SymBio Pharmaceuticals
SymBio Pharmaceuticals aims to develop drugs for patients overlooked by the industry, ensuring vital treatments reach those in need.
Launch date
Employees
Market cap
€77.3m
Enterprise valuation
€33m (Public information from Sep 2024)
Share price
JPY252 4582.T
Tokyo Japan (HQ)
Authorizing premium user...